Ibortin 12 Tablet contains Ivermectin 12 mg, an antiparasitic agent widely used for the treatment of various parasitic infections. Ivermectin acts by binding selectively and with high affinity to glutamate-gated chloride ion channels in invertebrate nerve and muscle cells, leading to increased permeability to chloride ions, hyperpolarization, and subsequent paralysis and death of the parasite. This medication is indicated for the treatment of strongyloidiasis, onchocerciasis, and other parasitic infestations caused by susceptible organisms. Ibortin 12 Tablet is administered orally, with dosage and duration dependent on the specific infection and patient characteristics. It is generally well tolerated, but potential side effects may include dizziness, gastrointestinal disturbances, rash, and mild transient elevations in liver enzymes. Caution is advised in patients with impaired liver function or those with a history of hypersensitivity to Ivermectin. It is contraindicated in patients with known hypersensitivity to any component of the formulation. Use during pregnancy should be avoided unless clearly necessary, and breastfeeding mothers should consult a healthcare provider before use. Ibortin 12 Tablet should be used under medical supervision to ensure appropriate dosing and monitoring for adverse effects and therapeutic efficacy.